Dow Down 3.39% Nasdaq Down 4.12%

ZIOPHARM Oncology, Inc. (ZIOP)

-NasdaqCM
5.64 Down 0.43(7.08%) 4:00PM EDT
|After Hours : 5.64 Down 0.00 (0.02%) 4:16PM EDT - Nasdaq Real Time Price
Prev Close:6.07
Open:5.75
Bid:5.67 x 300
Ask:6.08 x 300
1y Target Est:14.00
Beta:2.37154
Earnings Date:Aug 8 - Aug 12 (Est.)
Day's Range:5.61 - 6.02
52wk Range:4.56 - 14.93
Volume:2,886,088
Avg Vol (3m):2,308,930
Market Cap:734.45M
P/E (ttm):N/A
EPS (ttm):-0.42
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
ZIOPDown 7.08%734.45M
IMGNDown 5.72%272.55M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):131.10
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-0.43
Quarterly EPS Est (Jun-16) :-0.11
Mean Recommendation*:3.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

ZIOPHARM Oncology, Inc., a biotechnology company, focuses on acquiring, developing, and commercializing a portfolio of cancer therapies that address unmet medical needs through synthetic immuno-oncology. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback